http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61161290-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2be7f6ad58906afb472b880912f439f |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
filingDate | 1985-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14e00cdfa2dc7ec0ac951e82abbc3e15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f981017033213f66b853c65237e91e0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41c737235ec71dc38097f95845ad520d |
publicationDate | 1986-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S61161290-A |
titleOfInvention | Azulene phosphoric acid ester derivative and preparation thereof |
abstract | NEW MATERIAL:The compound of formula I (R 1 and R 2 are H or lower alkyl). n EXAMPLE: 1-Methyl-3-phosphonomethyl-azulene sodium salt. n USE: A cardiotonic agent effective to increase the constriction force of atrium. n PREPARATION: The objective derivative can be produced by reacting the compound of formula II (e.g. 1-hydroxymethyl-3-methylazulene) with phosphorus oxychloride in a solvent such as anhydrous ether in the presence of pyridine, and treating the produced compound with sodium acetate. n COPYRIGHT: (C)1986,JPO&Japio |
priorityDate | 1985-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.